Skip to main content
OpenTrials
Completed

NCT Number: NCT01020422

Sexuality After Reduction Mammaplasty

The aim of this study is to determine the impact of reduction mammaplasty on sexuality and depression predictors in women with macromastia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sexual Function Behavior Behavioral Symptoms Depression Gigantomastia Sexual Behavior Sexuality

Age range

18 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Hospital das Clínicas Samuel Libânio - UNIVÁS

Pouso Alegre, Minas Gerais, 37550000, Brazil

About this study

Breast hypertrophy is a common condition among women. Reduction mammaplasty is an effective and well established procedure performed for the relief discomfort associated with breast hypertrophy. Female breasts play an important role in sexuality, thus, the main purpose of this study is to determine whether reduction mammaplasty could influence sexual function and depression predictors on women with breast hypertrophy.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • breast hypertrophy
  • candidate to reduction mammaplasty
  • healthy volunteer with normal volume breasts (control group)
  • body mass index under 30Kg/m2

Exclusion criteria

  • pregnancy, delivery or breast feeding during the last 12 months
  • body mass index over 30Kg/m2
  • breast cancer history
  • previous breast surgery
  • hard smoking

Treatment and study plan

reduction mammaplasty

Procedure

Sexual function of patients undergoing reduction mammaplasty will be assessed by the Female Sexual Function Index (FSFI) preoperatively and 3 and 6 months postoperatively.

Other names: Breast reduction

Primary outcomes

  1. Sexual function

    Time frame: 6 months

    Sexual function will be assessed by the Female Sexual Function Index (FSFI), pre and 6 months postoperatively.

Secondary outcomes

  1. depression predictors

    Time frame: 6 months

    Depression predictors will me assessed by the Beck Depression Inventory (BDI) pre- and 6 months postoperatively.

Sponsors and collaborators

Lead sponsor

Daniela Francescato Veiga

Other

Collaborators

  • Universidade do Vale do Sapucai

Registry information

Official study title

Sexuality and Depression Predictors Among Breast Hypertrophy Women Undergoing Reduction Mammaplasty

Important dates

Study start
2008
Primary completion
2009
Study completion
2011
First posted
Nov 25, 2009
Registry last updated
Sep 6, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.